X-LINKED PROTOPORPHYRIA (XLP)
Clinical trials for X-LINKED PROTOPORPHYRIA (XLP) explained in plain language.
Never miss a new study
Get alerted when new X-LINKED PROTOPORPHYRIA (XLP) trials appear
Sign up with your email to follow new studies for X-LINKED PROTOPORPHYRIA (XLP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug could let Sun-Sensitive patients enjoy the outdoors Pain-Free
Disease control OngoingThis study tests whether the drug bitopertin can help people with erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP) spend more time in sunlight without pain. About 183 participants aged 12 and older will receive either bitopertin or a placebo for 6 months. Rese…
Matched conditions: X-LINKED PROTOPORPHYRIA (XLP)
Phase: PHASE3 • Sponsor: Disc Medicine, Inc • Aim: Disease control
Last updated May 19, 2026 11:59 UTC
-
New pill could let sun-sensitive patients enjoy daylight longer without burning pain.
Symptom relief OngoingThis study tests an experimental drug called MT-7117 in 165 adults and teens (ages 12-75) with erythropoietic protoporphyria or X-linked protoporphyria — rare conditions that cause severe pain, burning, or itching within minutes of sun exposure. Participants receive either the dr…
Matched conditions: X-LINKED PROTOPORPHYRIA (XLP)
Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Symptom relief
Last updated May 26, 2026 07:22 UTC